- 學位論文
疫苗製劑業創新經營模式研究
Research on innovative business model of vaccine industry
摘要
本論文旨在探討疫苗製劑業創新經營模式，以台灣產業為例。產業的營運是有其生命週期的，一但該企業開始衰敗或者該市場趨向於飽和現象時，就需要靠著『創新的經營模式』來改變企業現有整體的營運手段與未來規劃。本研究利用Osterwalder的經營模式九大構面因子進行分析，針對生產大分子藥品、蛋白製劑與疫苗之生產廠創新經營模式等鮮有相關之藥廠進行分析，並藉由藥品製造產業中大分子疫苗生產廠的經營模式之九大構面作為角度，來了解疫苗製藥廠，並設法從中找出最佳創新經營之道。 本文深入探討了創新的定義、理論，並以台灣某疫苗藥廠為例，分析其創新經營模式。首先，本文從創新的定義、類型、特徵等方面進行了詳細的介紹和分析。接著，本文以Osterwalder的商業模式九大構面因子作為分析框架，對該藥廠進行了深入的剖析，包括價值主張、顧客關係、通路、收入來源、關鍵資源、關鍵活動、合作夥伴、成本結構和客戶群等方面。 本篇論文發現，在受疫情影響的2023年台灣，疫苗製劑業依所屬的產業鏈的位置分為像似台積電的生產型公司與似高通的研發型公司，而這兩類型的公司是基於本身提供價值主張的方式不同，而造成後續經營模式的改變與未來規劃的不同。但都在透過瞭解大環境來進行不同程度的漸進式創新模式，達到更大的創新模式，最終促使企業維持持續競爭優勢，以創造更大的收益以及利潤。 基於以上分析結果，本文提出了一些實用建議：疫苗製劑業處於高科技產業，有利的創新模式還是著重於技術或產品創新。而企業應根據自身價值主張與在整體產業鏈中之類型，挑選企業所欠缺之部分，才能在市場競爭中保持優勢；另外，由於疫苗製劑業有著高度整合的特性，在部分人才與資源尚未成熟階段，疫苗製劑業應與合作夥伴建立良好的合作關係，共同實現協同發展；最後，疫苗製劑業尚須注重人才培養和管理創新，建立一支高素質的專業團隊…等，來整體的提高自身競爭力。 本論文通過對台灣疫苗藥廠的創新經營模式進行深入分析，提供了豐富的研究資料和實用建議，希望對疫苗製劑產業的發展和企業的創新經營具有一定的參考價值。未來，疫苗製劑產業將面臨更多的挑戰和機遇，企業需要不斷創新，探索出更加適合自身發展的經營模式，以保持競爭優勢。
並列摘要
This paper aims to explore innovative business models in the biotechnology industry, using the pharmaceutical industry in Taiwan as an example. Industries have their own life cycles, and when a company starts to decline or the market approaches saturation, it needs to rely on "innovative business models" to change its existing overall operations and future planning. This study utilizes Osterwalder's nine business model canvas factors for analysis, focusing on the analysis of innovative business models in pharmaceutical factories that are rarely associated with the production of macromolecular drugs, protein preparations, and vaccines. By using the nine factors of the business model of macromolecular vaccine production factories in the pharmaceutical manufacturing industry as a perspective, this study aims to understand vaccine pharmaceutical factories and identify the best ways for innovative business practices. This paper delves into the definition and theories of innovation and analyzes the innovative business model of a vaccine pharmaceutical factory in Taiwan as a case study. First, the paper provides a detailed introduction and analysis of the definition, types, and characteristics of innovation. Then, using Osterwalder's nine business model canvas factors as an analytical framework, the paper conducts an in-depth analysis of the pharmaceutical factory, including value proposition, customer relationships, channels, revenue streams, key resources, key activities, partnerships, cost structure, and customer segments. This paper finds that in the COVID-19-affected Taiwan of 2023, the vaccine manufacturing industry is divided into production-oriented companies resembling TSMC and research and development-oriented companies resembling Qualcomm, based on their position within the industry chain. The different model propositions of these two types of companies lead to changes in their subsequent business models and future plans. However, both types of companies employ incremental innovation models to varying degrees by understanding the macro environment, in order to achieve greater innovation. This ultimately enables the companies to maintain a competitive advantage and generate increased revenue and profit. Based on the above analysis, this paper offers practical recommendations. As the vaccine industry belongs to the high-tech sector, a favorable innovation model still emphasizes technological or product innovation. Companies should select the areas where they lack expertise based on their own value propositions and their position in the overall industry chain to maintain a competitive edge in the market. Additionally, due to the highly integrated nature of the vaccine industry, during stages where talent and resources are not yet mature, vaccine companies should establish good partnerships with collaborators to achieve synergistic development. Lastly, the vaccine industry should focus on talent cultivation and innovative management to build a highly skilled and professional team, thus enhancing overall competitiveness. By conducting an in-depth analysis of the innovative business model of a vaccine pharmaceutical factory in Taiwan, this paper provides valuable research insights and practical recommendations for the development of the biotechnology industry and innovative business practices. In the future, the biotechnology industry will face more challenges and opportunities, and companies need to continuously innovate and explore business models that are more suitable for their own development in order to maintain a competitive advantage.